Stocks and Investing
Stocks and Investing
Tue, January 31, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Li Watsek Reiterated (ARVN) at Buy and Held Target at $90 on, Jan 31st, 2023
Li Watsek of Cantor Fitzgerald, Reiterated "Arvinas, Inc." (ARVN) at Buy and Held Target at $90 on, Jan 31st, 2023.
Li has made no other calls on ARVN in the last 4 months.
There are 8 other peers that have a rating on ARVN. Out of the 8 peers that are also analyzing ARVN, 3 agree with Li's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Schmidt of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 12th, 2023
- Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $49 on, Tuesday, January 3rd, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Hold with Decreased Target to $57 on, Friday, November 11th, 2022
These are the ratings of the 5 analyists that currently disagree with Li
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $65 on, Tuesday, January 17th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $72 on, Monday, December 5th, 2022
- Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $70 on, Wednesday, November 23rd, 2022
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $81 on, Wednesday, November 23rd, 2022
- Peter Lawson of "Barclays" Maintained at Buy with Decreased Target to $70 on, Wednesday, November 23rd, 2022
Contributing Sources